Unleashing the antibacterial and antibiofilm potential of silica-based nanomaterials functionalized with an organotin( iv ) compound

Autores
García Almodóvar, Victoria; Ardiles, Perla del Rosario; Prashar, Sanjiv; Páez, Paulina Laura; Gómez Ruiz, Santiago
Año de publicación
2024
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
Bacterial diseases caused by superbugs are expected to be the main cause of death worldwide within a decade as a consequence of the resistance they are acquiring to the antibiotics currently in use, therefore, the field of new antibacterial treatments is currently being thoroughly studied. The presentwork focuses on the synthesis, functionalization, characterization and antibacterial behaviour of different systems based on three different silica-based nanostructured materials (MSN, mesoporous silica nanoparticles, SBA-15 Santa Barbara amorphous-15 and FSP fibrous slica nanoparticles) which serve asscaffolds for the support of different platforms to target and treat bacterial diseases and biofilm formation. Thus, (3-carboxypropyl)triphenylphosphonium bromide (PPh3+) and a cytotoxic organotin(IV) fragment (Sn) have been incorporated in the silica-based materials to study their potential activity indifferent antibacterial applications. After a complete characterization of the synthesized systems, which confirmed the incorporation of both the targeting and the therapeutic fragments within the nanostructured materials, the antibacterial study of the materials demonstrated bactericidal capacity against Escherichia coli and perturbation of the bacteria metabolism via oxidative stress through anenhanced ROS (reactive oxygen species) production. In addition, biofilm inhibition and eradication tests of bacterial strains were carried out, showing that the activity of the materials in both biofilm inhibition and eradication is dependent on the concentration of the material. Furthemore, the material MSNAP(1:1)-PPh3+-Sn containing the targeting triphenylphosphonium and a ??SnPh3?? fragment is capable of inhibiting and eradicating up to 50% of the formation of biofilms, which is outstanding for metallodrugfunctionalized silica-based systems compared with other materials based on metal nanoparticlessupported on silica. Finally, a hemolysis study was carried out with the nanostructured systems proving to be non-toxic, making them adequate for their subsequent use in preclinical trials through in vivo models.
Fil: García Almodóvar, Victoria. Universidad Rey Juan Carlos; España
Fil: Ardiles, Perla del Rosario. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas; Argentina
Fil: Prashar, Sanjiv. Universidad Rey Juan Carlos; España
Fil: Páez, Paulina Laura. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba. Unidad de Investigación y Desarrollo en Tecnología Farmacéutica. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas. Unidad de Investigación y Desarrollo en Tecnología Farmacéutica; Argentina
Fil: Gómez Ruiz, Santiago. Universidad Rey Juan Carlos; España
Materia
Antibacterial
Antibiofilm
Functionalized nanomaterials
Mesoporous silica nanoparticles
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by-nc/2.5/ar/
Repositorio
CONICET Digital (CONICET)
Institución
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador
oai:ri.conicet.gov.ar:11336/260778

id CONICETDig_2cc61dfc53d74296f0baad0eba849f5c
oai_identifier_str oai:ri.conicet.gov.ar:11336/260778
network_acronym_str CONICETDig
repository_id_str 3498
network_name_str CONICET Digital (CONICET)
spelling Unleashing the antibacterial and antibiofilm potential of silica-based nanomaterials functionalized with an organotin( iv ) compoundGarcía Almodóvar, VictoriaArdiles, Perla del RosarioPrashar, SanjivPáez, Paulina LauraGómez Ruiz, SantiagoAntibacterialAntibiofilmFunctionalized nanomaterialsMesoporous silica nanoparticleshttps://purl.org/becyt/ford/1.4https://purl.org/becyt/ford/1Bacterial diseases caused by superbugs are expected to be the main cause of death worldwide within a decade as a consequence of the resistance they are acquiring to the antibiotics currently in use, therefore, the field of new antibacterial treatments is currently being thoroughly studied. The presentwork focuses on the synthesis, functionalization, characterization and antibacterial behaviour of different systems based on three different silica-based nanostructured materials (MSN, mesoporous silica nanoparticles, SBA-15 Santa Barbara amorphous-15 and FSP fibrous slica nanoparticles) which serve asscaffolds for the support of different platforms to target and treat bacterial diseases and biofilm formation. Thus, (3-carboxypropyl)triphenylphosphonium bromide (PPh3+) and a cytotoxic organotin(IV) fragment (Sn) have been incorporated in the silica-based materials to study their potential activity indifferent antibacterial applications. After a complete characterization of the synthesized systems, which confirmed the incorporation of both the targeting and the therapeutic fragments within the nanostructured materials, the antibacterial study of the materials demonstrated bactericidal capacity against Escherichia coli and perturbation of the bacteria metabolism via oxidative stress through anenhanced ROS (reactive oxygen species) production. In addition, biofilm inhibition and eradication tests of bacterial strains were carried out, showing that the activity of the materials in both biofilm inhibition and eradication is dependent on the concentration of the material. Furthemore, the material MSNAP(1:1)-PPh3+-Sn containing the targeting triphenylphosphonium and a ??SnPh3?? fragment is capable of inhibiting and eradicating up to 50% of the formation of biofilms, which is outstanding for metallodrugfunctionalized silica-based systems compared with other materials based on metal nanoparticlessupported on silica. Finally, a hemolysis study was carried out with the nanostructured systems proving to be non-toxic, making them adequate for their subsequent use in preclinical trials through in vivo models.Fil: García Almodóvar, Victoria. Universidad Rey Juan Carlos; EspañaFil: Ardiles, Perla del Rosario. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas; ArgentinaFil: Prashar, Sanjiv. Universidad Rey Juan Carlos; EspañaFil: Páez, Paulina Laura. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba. Unidad de Investigación y Desarrollo en Tecnología Farmacéutica. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas. Unidad de Investigación y Desarrollo en Tecnología Farmacéutica; ArgentinaFil: Gómez Ruiz, Santiago. Universidad Rey Juan Carlos; EspañaRoyal Society of Chemistry2024-09info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/260778García Almodóvar, Victoria; Ardiles, Perla del Rosario; Prashar, Sanjiv; Páez, Paulina Laura; Gómez Ruiz, Santiago; Unleashing the antibacterial and antibiofilm potential of silica-based nanomaterials functionalized with an organotin( iv ) compound; Royal Society of Chemistry; Journal of Materials Chemistry B; 12; 36; 9-2024; 9056-90732050-750X2050-7518CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://xlink.rsc.org/?DOI=D4TB01106Finfo:eu-repo/semantics/altIdentifier/doi/10.1039/D4TB01106Finfo:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-10T13:04:38Zoai:ri.conicet.gov.ar:11336/260778instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-10 13:04:38.761CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv Unleashing the antibacterial and antibiofilm potential of silica-based nanomaterials functionalized with an organotin( iv ) compound
title Unleashing the antibacterial and antibiofilm potential of silica-based nanomaterials functionalized with an organotin( iv ) compound
spellingShingle Unleashing the antibacterial and antibiofilm potential of silica-based nanomaterials functionalized with an organotin( iv ) compound
García Almodóvar, Victoria
Antibacterial
Antibiofilm
Functionalized nanomaterials
Mesoporous silica nanoparticles
title_short Unleashing the antibacterial and antibiofilm potential of silica-based nanomaterials functionalized with an organotin( iv ) compound
title_full Unleashing the antibacterial and antibiofilm potential of silica-based nanomaterials functionalized with an organotin( iv ) compound
title_fullStr Unleashing the antibacterial and antibiofilm potential of silica-based nanomaterials functionalized with an organotin( iv ) compound
title_full_unstemmed Unleashing the antibacterial and antibiofilm potential of silica-based nanomaterials functionalized with an organotin( iv ) compound
title_sort Unleashing the antibacterial and antibiofilm potential of silica-based nanomaterials functionalized with an organotin( iv ) compound
dc.creator.none.fl_str_mv García Almodóvar, Victoria
Ardiles, Perla del Rosario
Prashar, Sanjiv
Páez, Paulina Laura
Gómez Ruiz, Santiago
author García Almodóvar, Victoria
author_facet García Almodóvar, Victoria
Ardiles, Perla del Rosario
Prashar, Sanjiv
Páez, Paulina Laura
Gómez Ruiz, Santiago
author_role author
author2 Ardiles, Perla del Rosario
Prashar, Sanjiv
Páez, Paulina Laura
Gómez Ruiz, Santiago
author2_role author
author
author
author
dc.subject.none.fl_str_mv Antibacterial
Antibiofilm
Functionalized nanomaterials
Mesoporous silica nanoparticles
topic Antibacterial
Antibiofilm
Functionalized nanomaterials
Mesoporous silica nanoparticles
purl_subject.fl_str_mv https://purl.org/becyt/ford/1.4
https://purl.org/becyt/ford/1
dc.description.none.fl_txt_mv Bacterial diseases caused by superbugs are expected to be the main cause of death worldwide within a decade as a consequence of the resistance they are acquiring to the antibiotics currently in use, therefore, the field of new antibacterial treatments is currently being thoroughly studied. The presentwork focuses on the synthesis, functionalization, characterization and antibacterial behaviour of different systems based on three different silica-based nanostructured materials (MSN, mesoporous silica nanoparticles, SBA-15 Santa Barbara amorphous-15 and FSP fibrous slica nanoparticles) which serve asscaffolds for the support of different platforms to target and treat bacterial diseases and biofilm formation. Thus, (3-carboxypropyl)triphenylphosphonium bromide (PPh3+) and a cytotoxic organotin(IV) fragment (Sn) have been incorporated in the silica-based materials to study their potential activity indifferent antibacterial applications. After a complete characterization of the synthesized systems, which confirmed the incorporation of both the targeting and the therapeutic fragments within the nanostructured materials, the antibacterial study of the materials demonstrated bactericidal capacity against Escherichia coli and perturbation of the bacteria metabolism via oxidative stress through anenhanced ROS (reactive oxygen species) production. In addition, biofilm inhibition and eradication tests of bacterial strains were carried out, showing that the activity of the materials in both biofilm inhibition and eradication is dependent on the concentration of the material. Furthemore, the material MSNAP(1:1)-PPh3+-Sn containing the targeting triphenylphosphonium and a ??SnPh3?? fragment is capable of inhibiting and eradicating up to 50% of the formation of biofilms, which is outstanding for metallodrugfunctionalized silica-based systems compared with other materials based on metal nanoparticlessupported on silica. Finally, a hemolysis study was carried out with the nanostructured systems proving to be non-toxic, making them adequate for their subsequent use in preclinical trials through in vivo models.
Fil: García Almodóvar, Victoria. Universidad Rey Juan Carlos; España
Fil: Ardiles, Perla del Rosario. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas; Argentina
Fil: Prashar, Sanjiv. Universidad Rey Juan Carlos; España
Fil: Páez, Paulina Laura. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba. Unidad de Investigación y Desarrollo en Tecnología Farmacéutica. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas. Unidad de Investigación y Desarrollo en Tecnología Farmacéutica; Argentina
Fil: Gómez Ruiz, Santiago. Universidad Rey Juan Carlos; España
description Bacterial diseases caused by superbugs are expected to be the main cause of death worldwide within a decade as a consequence of the resistance they are acquiring to the antibiotics currently in use, therefore, the field of new antibacterial treatments is currently being thoroughly studied. The presentwork focuses on the synthesis, functionalization, characterization and antibacterial behaviour of different systems based on three different silica-based nanostructured materials (MSN, mesoporous silica nanoparticles, SBA-15 Santa Barbara amorphous-15 and FSP fibrous slica nanoparticles) which serve asscaffolds for the support of different platforms to target and treat bacterial diseases and biofilm formation. Thus, (3-carboxypropyl)triphenylphosphonium bromide (PPh3+) and a cytotoxic organotin(IV) fragment (Sn) have been incorporated in the silica-based materials to study their potential activity indifferent antibacterial applications. After a complete characterization of the synthesized systems, which confirmed the incorporation of both the targeting and the therapeutic fragments within the nanostructured materials, the antibacterial study of the materials demonstrated bactericidal capacity against Escherichia coli and perturbation of the bacteria metabolism via oxidative stress through anenhanced ROS (reactive oxygen species) production. In addition, biofilm inhibition and eradication tests of bacterial strains were carried out, showing that the activity of the materials in both biofilm inhibition and eradication is dependent on the concentration of the material. Furthemore, the material MSNAP(1:1)-PPh3+-Sn containing the targeting triphenylphosphonium and a ??SnPh3?? fragment is capable of inhibiting and eradicating up to 50% of the formation of biofilms, which is outstanding for metallodrugfunctionalized silica-based systems compared with other materials based on metal nanoparticlessupported on silica. Finally, a hemolysis study was carried out with the nanostructured systems proving to be non-toxic, making them adequate for their subsequent use in preclinical trials through in vivo models.
publishDate 2024
dc.date.none.fl_str_mv 2024-09
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/260778
García Almodóvar, Victoria; Ardiles, Perla del Rosario; Prashar, Sanjiv; Páez, Paulina Laura; Gómez Ruiz, Santiago; Unleashing the antibacterial and antibiofilm potential of silica-based nanomaterials functionalized with an organotin( iv ) compound; Royal Society of Chemistry; Journal of Materials Chemistry B; 12; 36; 9-2024; 9056-9073
2050-750X
2050-7518
CONICET Digital
CONICET
url http://hdl.handle.net/11336/260778
identifier_str_mv García Almodóvar, Victoria; Ardiles, Perla del Rosario; Prashar, Sanjiv; Páez, Paulina Laura; Gómez Ruiz, Santiago; Unleashing the antibacterial and antibiofilm potential of silica-based nanomaterials functionalized with an organotin( iv ) compound; Royal Society of Chemistry; Journal of Materials Chemistry B; 12; 36; 9-2024; 9056-9073
2050-750X
2050-7518
CONICET Digital
CONICET
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/url/https://xlink.rsc.org/?DOI=D4TB01106F
info:eu-repo/semantics/altIdentifier/doi/10.1039/D4TB01106F
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by-nc/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/pdf
application/pdf
dc.publisher.none.fl_str_mv Royal Society of Chemistry
publisher.none.fl_str_mv Royal Society of Chemistry
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1842980160264994816
score 12.993085